Evidence map›Paper›PMID 25551665›Full record

ArticleNature protocols2015

A high-throughput in vivo micronucleus assay for genome instability screening in mice.

Gabriel Balmus, Natasha A Karp, Bee Ling Ng, Stephen P Jackson, David J Adams, Rebecca E McIntyre

Open access · greenAbstract read
In one paragraph

Article in Nature protocols, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Micronuclei: origins, assays, mechanisms, diseases and treatments.Signal transduction and targeted therapy · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Deciphering the aging process through single-cell cytometric technologies.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Cell genomics · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gabriel Balmus1] The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK. [2] Maintenance of Genome Stability, The Wellcome Trust Sanger Institute, Genome Campus, Cambridge, UK.
Natasha A KarpThe Sanger Mouse Genetics Project, The Wellcome Trust Sanger Institute, Genome Campus, Cambridge, UK.
Bee Ling NgCytometry Core Facility, The Wellcome Trust Sanger Institute, Genome Campus, Cambridge, UK.
Stephen P Jackson1] The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK. [2] Maintenance of Genome Stability, The Wellcome Trust Sanger Institute, Genome Campus, Cambridge, UK.
David J AdamsExperimental Cancer Genetics, The Wellcome Trust Sanger Institute, Genome Campus, Cambridge, UK.
Rebecca E McIntyreExperimental Cancer Genetics, The Wellcome Trust Sanger Institute, Genome Campus, Cambridge, UK.
Wellcome Sanger Institute · GBWellcome Trust · GB

Funding

Cancer Research UK 11224Cancer Research UK 12401Cancer Research UK A11224Cancer Research UK C20510/A12401Cancer Research UK C6946/A14492Cancer Research UK C6/A11224European Research Council 268536Wellcome TrustWellcome Trust WT092096
6 · The paper itself

Abstract

We describe a sensitive, robust, high-throughput method for quantifying the formation of micronuclei, markers of genome instability, in mouse erythrocytes. Micronuclei are whole chromosomes or chromosome segments that have been separated from the nucleus. Other methods of detection rely on labor-intensive, microscopy-based techniques. Here we describe a 2-d, 96-well plate-based flow cytometric method of micronucleus scoring that is simple enough for a research technician experienced in flow cytometry to perform. The assay detects low levels of genome instability that cannot be readily identified by classic phenotyping, using 25 μl of blood. By using this assay, we have screened >10,000 blood samples and discovered novel genes that contribute to vertebrate genome maintenance, as well as novel disease models and mechanisms of genome instability disorders. We discuss experimental design considerations, including statistical power calculation, we provide troubleshooting tips and we discuss factors that contribute to a false-positive increase in the number of micronucleated red blood cells and to experimental variability.

Indexed as

AnimalsErythrocytesErythropoiesisFlow CytometryGenomic InstabilityHigh-Throughput Screening AssaysMiceMicronucleus Tests

Identifiers

PMID25551665
PMCPMC4806852
OpenAlexW2004568915

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.